Stock Track | Alphatec Plunges 20.04% in Pre-Market on Q1 Revenue Miss, $34M Loss, and Analyst Downgrades

Stock Track
May 06

Alphatec Holdings (NASDAQ: ATEC) experienced a sharp pre-market decline of 20.04% on Wednesday, following the release of its first-quarter 2026 financial results and subsequent analyst price target cuts.

The medical device company reported quarterly revenue of $192.108 million, which fell short of the analyst consensus estimate of $197.345 million. Despite showing a 13.55% year-over-year increase, the revenue miss disappointed investors. The company also posted a net loss of $34 million for the quarter, with a basic loss per share of $0.22.

Adding to the negative sentiment, major financial institutions revised their outlook on the stock. JP Morgan slashed its price target on Alphatec to $16 from $24, while Piper Sandler cut its target to $14 from $25. Concurrently, the company announced a debt refinancing initiative involving a new $300 million credit facility, which management stated is expected to reduce annual interest expense by over $6 million.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10